ADAR1 Capital Management »

Adicet Bio shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Adicet Bio (ACET) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Adicet Bio

Tip: Access up to 7 years of quarterly data

All positions including Adicet Bio held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adicet Bio by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $73k 31k 2.35

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Adicet Bio

OrbiMed Advisors
Tang Capital Management
RA Capital Management
Goldman Sachs Group
Vanguard Group
Carlyle
Aquilo Capital Management
Acadian Asset Management
Blackstone Group
Renaissance Technologies
Morgan Stanley
BlackRock
D. E. Shaw & Co
Geode Capital Management
BlackRock

View all funds holding Adicet Bio